HCPCS Level II code Q4115 describes Alloskin billed per square centimeter, an add-on supply code used when biologic allograft skin is provided in addition to a primary surgical or wound-care procedure. This code matters nationally as biologic skin grafts are used in complex wound management and burn care and can represent a significant component of procedural supply costs. Coverage and billing practice variation across major payers affect access to these products and facility reimbursement.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of allograft skin, common sites of service where the product is applied, and typical service types tied to the code. The publication highlights where data is available on payer coverage and coding applications, and it identifies gaps where input was not provided.

The content provides benchmarking context, policy and coding considerations relevant to facilities and billing teams, and practical detail on the nature of the service associated with Q4115. Data not available in the input is noted where applicable; the focus remains on national applicability rather than state-specific policies.